Massimo Pacilli

3.1k total citations
24 papers, 319 citations indexed

About

Massimo Pacilli is a scholar working on Infectious Diseases, Epidemiology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Massimo Pacilli has authored 24 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 8 papers in Epidemiology and 7 papers in Applied Microbiology and Biotechnology. Recurrent topics in Massimo Pacilli's work include Antibiotic Use and Resistance (7 papers), SARS-CoV-2 detection and testing (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Massimo Pacilli is often cited by papers focused on Antibiotic Use and Resistance (7 papers), SARS-CoV-2 detection and testing (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Massimo Pacilli collaborates with scholars based in United States, Japan and United Kingdom. Massimo Pacilli's co-authors include Stéphanie Black, Tristan D. McPherson, Janna L. Kerins, Isaac Ghinai, Jennifer E. Layden, Marielle Fricchione, Peter Ruestow, M. Allison Arwady, Susan Woods and Kathleen A. Ritger and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and The Science of The Total Environment.

In The Last Decade

Massimo Pacilli

21 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Massimo Pacilli United States 8 159 112 67 53 44 24 319
Laura Espenhain Denmark 12 167 1.1× 79 0.7× 35 0.5× 26 0.5× 23 0.5× 25 379
Hassan El Bushra Saudi Arabia 12 176 1.1× 110 1.0× 71 1.1× 59 1.1× 17 0.4× 29 406
Xiang Ma China 12 336 2.1× 245 2.2× 33 0.5× 184 3.5× 44 1.0× 47 674
Hester Allen United Kingdom 10 250 1.6× 61 0.5× 90 1.3× 60 1.1× 21 0.5× 19 367
Ismar A. Rivera‐Olivero Ecuador 13 138 0.9× 244 2.2× 38 0.6× 54 1.0× 27 0.6× 34 437
Utpala Bandy United States 10 137 0.9× 244 2.2× 32 0.5× 156 2.9× 30 0.7× 43 377
Daniel A. Solomon United States 9 154 1.0× 196 1.8× 18 0.3× 34 0.6× 14 0.3× 30 393
Wendy Chung United States 8 155 1.0× 90 0.8× 36 0.5× 29 0.5× 8 0.2× 18 296
Aurora Limia Spain 9 139 0.9× 134 1.2× 38 0.6× 34 0.6× 14 0.3× 15 286
Jinren Pan China 13 152 1.0× 154 1.4× 108 1.6× 44 0.8× 35 0.8× 31 410

Countries citing papers authored by Massimo Pacilli

Since Specialization
Citations

This map shows the geographic impact of Massimo Pacilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Pacilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Pacilli more than expected).

Fields of papers citing papers by Massimo Pacilli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Pacilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Pacilli. The network helps show where Massimo Pacilli may publish in the future.

Co-authorship network of co-authors of Massimo Pacilli

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Pacilli. A scholar is included among the top collaborators of Massimo Pacilli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Pacilli. Massimo Pacilli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barbian, Hannah J., Richard A. Teran, Xueting Qiu, et al.. (2024). A response playbook for early detection and population surveillance of new SARS-CoV-2 variants in a regional public health laboratory. BMC Public Health. 24(1). 59–59.
2.
DeJonge, Peter M., Janna L. Kerins, Rachel Poretsky, et al.. (2024). Using wastewater surveillance for mpox as a complement to traditional case-based reporting – Chicago, March–June 2023. Environment International. 190. 108749–108749. 4 indexed citations
3.
Mayer, Stockton, et al.. (2024). Academic Medical Center–Public Health Partnerships for Outbreak Response — Collaborating with Underresourced Communities. New England Journal of Medicine. 391(8). 679–681.
4.
Yüce, Deniz, Kelley Bemis, Stephanie Gretsch, et al.. (2023). Correlation of wastewater surveillance data with traditional influenza surveillance measures in Cook County, Illinois, October 2022–April 2023. The Science of The Total Environment. 912. 169551–169551. 7 indexed citations
5.
Walblay, Kelly, et al.. (2023). Health Care Personnel Exposure Risk Assessment and Management During a Mpox Outbreak in Chicago, Illinois, 17 May to 8 July 2022. The Journal of Infectious Diseases. 229(Supplement_2). S207–S212. 1 indexed citations
6.
Teran, Richard A., Stephanie Gretsch, Kelly Walblay, et al.. (2023). SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022. Emerging infectious diseases. 29(11). 2257–2265. 1 indexed citations
7.
Arevalo, Philip, Katelyn M. Gostic, Massimo Pacilli, et al.. (2022). Tracking changes in SARS-CoV-2 transmission with a novel outpatient sentinel surveillance system in Chicago, USA. Nature Communications. 13(1). 5547–5547. 4 indexed citations
8.
Doyle, Kate, Richard A. Teran, Jennita Reefhuis, et al.. (2021). Multiple Variants of SARS-CoV-2 in a University Outbreak After Spring Break — Chicago, Illinois, March–May 2021. MMWR Morbidity and Mortality Weekly Report. 70(35). 1195–1200. 17 indexed citations
9.
Sexton, D. Joseph, Meghan L. Bentz, Rory M. Welsh, et al.. (2021). Positive Correlation Between Candida auris Skin-Colonization Burden and Environmental Contamination at a Ventilator-Capable Skilled Nursing Facility in Chicago. Clinical Infectious Diseases. 73(7). 1142–1148. 50 indexed citations
10.
Arwady, M. Allison, et al.. (2021). Community-Based Testing for SARS-CoV-2 — Chicago, Illinois, May–November 2020. MMWR Morbidity and Mortality Weekly Report. 70(19). 707–711. 5 indexed citations
11.
McPherson, Tristan D., Kelly Walblay, Latania K. Logan, et al.. (2020). Notes from the Field: Candida auris and Carbapenemase-Producing Organism Prevalence in a Pediatric Hospital Providing Long-Term Transitional Care — Chicago, Illinois, 2019. MMWR Morbidity and Mortality Weekly Report. 69(34). 1180–1181. 2 indexed citations
14.
Glowicz, Janet, Matthew B. Crist, Carolyn Gould, et al.. (2018). A multistate investigation of health care–associated Burkholderia cepacia complex infections related to liquid docusate sodium contamination, January-October 2016. American Journal of Infection Control. 46(6). 649–655. 25 indexed citations
15.
Kerins, Janna L., Kaitlin Forsberg, Massimo Pacilli, et al.. (2018). 923. Rapid Emergence of Candida auris in the Chicago Region. Open Forum Infectious Diseases. 5(suppl_1). S28–S28. 5 indexed citations
16.
Folaranmi, Temitope, Cécilia B. Kretz, Hajime Kamiya, et al.. (2017). Increased Risk for Meningococcal Disease Among Men Who Have Sex With Men in the United States, 2012–2015. Clinical Infectious Diseases. 65(5). 756–763. 55 indexed citations
17.
Lin, Michael Y., Karen Lolans, David A. Wirth, et al.. (2017). The Importance of Ventilator Skilled Nursing Facilities (vSNFs) in the Regional Epidemiology of Carbapenemase-Producing Organisms (CPOs). Open Forum Infectious Diseases. 4(suppl_1). S137–S138. 5 indexed citations
18.
19.
Whaley, Melissa, Hajime Kamiya, Jessica R. MacNeil, et al.. (2016). Meningococcal Disease Among Men Who Have Sex with Men—United States, 2012–2015. Open Forum Infectious Diseases. 3(suppl_1). 3 indexed citations
20.
Pacilli, Massimo, Margaret M. Cortese, Alicia M. Siston, et al.. (2015). Outbreak of Gastroenteritis in Adults Due to Rotavirus Genotype G12P[8]. Clinical Infectious Diseases. 61(4). e20–e25. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026